Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 24, 2001

View Archived Issues

Low Share Prices, Cash Positions Expected To Trigger M&A Activity

Some EU Member States Resist Lifting Moratorium On GMOs

French Government Agrees On Measures To Support Biotech

Tissue Engineering Draws Much Interest At German Trade Fair

Axxima Raises EUR30.6M In Third Financing Round

IntegraGen Secures Access To Obesity, Diabetes Gene Data

Berna Biotech, Bachem Enter Joint Venture For Peptide Vaccines

Other News To Note

Transgene Takes Gene Therapy Product Into Phase II Studies

ReGen Raising Funds To Move Colostrinin Trials Forward

De Novo, Roche Collaborate On Chemical Design Platform

MediGene Gets Positive Results In First Genital Warts Phase III

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...